RESUMEN
Sepsis-induced acute lung injury (ALI) is a serious sepsis complication and the prevailing cause of death. Circulating plasma exosomes might exert a key role in regulating intercellular communication between immunological and structural cells, as well as contributing to sepsis-related organ damage. However, the molecular mechanisms by which exosome-mediated intercellular signaling exacerbate ALI in septic infection remains undefined. Therefore, we investigated the effect of macrophage-derived exosomal APN/CD13 on the induction of epithelial cell necrosis. Exosomal APN/CD13 levels in the plasma of septic mice and patients with septic ALI were found to be higher. Furthermore, increased plasma exosomal APN/CD13 levels were associated with the severity of ALI and fatality in sepsis patients. We found remarkably high expression of APN/CD13 in exosomes secreted by LPS-stimulated macrophages. Moreover, c-Myc directly induced APN/CD13 expression and was packed into exosomes. Finally, exosomal APN/CD13 from macrophages regulated necroptosis of lung epithelial cells by binding to the cell surface receptor TLR4 to induce ROS generation, mitochondrial dysfunction and NF-κB activation. These results demonstrate that macrophage-secreted exosomal APN/CD13 can trigger epithelial cell necroptosis in an APN/CD13-dependent manner, which provides insight into the mechanism of epithelial cell functional disorder in sepsis-induced ALI.
Asunto(s)
Lesión Pulmonar Aguda , Sepsis , Lesión Pulmonar Aguda/complicaciones , Animales , Antígenos CD13/farmacología , Células Epiteliales , Humanos , Pulmón , Macrófagos , Ratones , Necroptosis , Sepsis/complicacionesRESUMEN
BACKGROUND: According to the World Health Organization reports, billions of people around the world are at risk for malaria disease and it is important to consider the preventive strategies for protecting the people that are living in high risk areas. One of the main reasons of disease survival is diversity of vectors and parasites in different malaria regions that have their specific features, behaviour and biology. Therefore, specific regional strategies are necessary for successful control of malaria. One of the tools that needs to be developed for elimination and prevention of reintroduction of malaria is a vaccine that interrupt malaria transmission (VIMTs). VIMT is a broad concept that should be adjusted to the biological characteristics of the disease in each region. One type of VIMT is a vector-based vaccine that affects the sexual stage of Plasmodium life cycle. According to recent studies, the aminopeptidase N-1 of Anopheles gambiae (AgAPN-1) is as a potent vector-based VIMT with considerable inhibition activity against the sexual stage of Plasmodium parasite. METHODS: Systems for rapid amplification of cDNA ends (3'-RACE) and genome walking methods were used for sequence determination of apn-1 gene from Anopheles stephensi and distinct bioinformatics software were used for structural analysis. AsAPN-1 was expressed in Spodoptera frugiperda (Sf9) insect cell line using the baculovirus expression system. Recombinant AsAPN-1 was purified under the hybrid condition and its biological activity was assayed. RESULTS: Asapn-1 gene and its coded protein from An. stephensi were characterized for the first time in this study. Subsequently, the structural features and immunological properties of its coded protein were evaluated by in silico approaches. Enzymatic activity of the recombinant AsAPN-1, which was expressed in Sf9 insect cell line, was equal to 6 unit/µl. CONCLUSIONS: Results of this study revealed that AsAPN-1 is very similar to its counterpart in An. gambiae. In silico evaluation and fundamental data which are necessary for its evaluation as a VIMT-based vaccine in the next steps were acquired in this study and those could be useful for research groups that study on malaria vaccine for countries that An. stephensi is the main malaria vector there.
Asunto(s)
Anopheles/genética , Antígenos CD13/farmacología , Proteínas de Insectos/genética , Malaria/prevención & control , Plasmodium falciparum/inmunología , Animales , Anopheles/enzimología , Proteínas de Insectos/farmacología , Vacunas contra la Malaria/inmunología , Células Sf9 , SpodopteraRESUMEN
The M1 family of metalloproteases represents a large number of exopeptidases that cleave single amino acid residues from the N-terminus of peptide substrates. One member of this family that has been well studied is aminopeptidase N (APN), a multifunctional protease known to cleave biologically active peptides and aide in coronavirus entry. The proteolytic activity of APN promotes cancer angiogenesis and metastasis making it an important target for cancer therapy. To understand the substrate specificity of APN for the development of targeted inhibitors, we used a global substrate profiling method to determine the P1-P4' amino acid preferences. The key structural features of the APN pharmacophore required for substrate recognition were elucidated by x-ray crystallography. By combining these substrate profiling and structural data, we were able to design a selective peptide inhibitor of APN that was an effective therapeutic both in vitro and in vivo against APN-expressing prostate cancer models.
Asunto(s)
Antígenos CD13/química , Antígenos CD13/farmacología , Diseño de Fármacos , Animales , Antineoplásicos/farmacología , Antígenos CD13/antagonistas & inhibidores , Cristalografía por Rayos X , Humanos , Masculino , Ratones Desnudos , Neoplasias/tratamiento farmacológico , Células PC-3 , Estructura Terciaria de Proteína , Proteínas Recombinantes , Especificidad por Sustrato , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Aspargine-glycine-arginine (NGR)-containing peptides are targeted peptides which can be integrated with CD13 receptors on tumor vascular endothelial cells. NGR peptides are connected to liposomes to obtain NGR peptide-modified liposomes. By intravenous injection of these liposomes, NGR peptides can be combined with CD13 receptors on tumor vascular endothelial cells, position liposomes in tumor tissues, and concentrate drug in liposomes in tumor, so as to enhance the antitumor effect. The article starts with NGR peptides, summarizes definition of NGR, NGR peptide-modified liposomes, strengths and weaknesses of NGR peptide-modified liposomes in antitumor and the latest study orientation of NGR peptide-modified liposomes, and looks into the future of studies on NGR peptide-modified liposomes.
Asunto(s)
Antineoplásicos/farmacología , Antígenos CD13/administración & dosificación , Oligopéptidos/administración & dosificación , Animales , Antígenos CD13/farmacología , Humanos , Liposomas , Oligopéptidos/farmacologíaRESUMEN
ZO-1 is a peripheral protein that plays a central role in the macromolecular assembly of tight junctions by interacting with integral proteins (occludin, claudins, JAMs) of the membrane of adjoining cells, with the actin cytoskeleton, and with nuclear factors. Human ZO-1 is expressed in all epithelia and some specialized endothelia as variable amounts of two related isoforms, which originate from the alternatively spliced mRNA transcripts alpha(+) and alpha(-) and whose specific differential role is still unknown. Moreover, little is known about the timing of expression of ZO-1 isoforms at the protein and mRNA level. This study shows that during growth of freshly plated Caco-2 cells, the alpha(+)/alpha(-) ratio increased as a result of simultaneous increase of alpha(+) and decrease of alpha(-). Differences in the isoform ratio also correlated with differences in epithelium differentiation. This was determined by aminopeptidase N measurements of cells grown on conventional substrates and on modified, micro/nano-patterned surfaces. A comparable shift of ZO-1 isoforms was not observed in other tumour cell lines of non-intestinal origin (A549, Calu-3). Pancreatic stem cells, propagated without exogenous differentiation stimuli, displayed a slight, stable prevalence of the alpha(-) isoform. Of the intestinal cell lines examined (Caco-2 and T84), only Caco-2 cells displayed a dramatic shift in isoform expression. This suggests that this tumour cell line retains to a higher degree a developmental programme related to the dynamic of enterocytic differentiation in vivo.
Asunto(s)
Proteínas de la Membrana/metabolismo , Fosfoproteínas/metabolismo , Empalme Alternativo , Antígenos CD13/farmacología , Células CACO-2 , Diferenciación Celular , Línea Celular , Humanos , Proteínas de la Membrana/genética , Fosfoproteínas/genética , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , ARN Mensajero/metabolismo , Proteína de la Zonula Occludens-1RESUMEN
We have designed a PEGylated LPD (liposome-polycation-DNA) nanoparticle for systemic, specific, and efficient delivery of small interfering RNA (siRNA) into solid tumors in mice by modification with NGR (aspargine-glycine-arginine) peptide, targeting aminopeptidase N (CD13) expressed in the tumor cells or tumor vascular endothelium. LPD-PEG-NGR efficiently delivered siRNA to the cytoplasm and downregulated the target gene in the HT-1080 cells but not CD13(-) HT-29 cells, whereas nanoparticles containing a control peptide, LPD-PEG-ARA, showed only little siRNA uptake and gene silencing activity. LPD-PEG-NGR efficiently delivered siRNA into the cytoplasm of HT-1080 xenograft tumor 4 hours after intravenous injection. Three daily injections (1.2 mg/kg) of c-myc siRNA formulated in the LPD-PEG-NGR effectively suppressed c-myc expression and triggered cellular apoptosis in the tumor, resulting in a partial tumor growth inhibition. When doxorubicin (DOX) and siRNA were co-formulated in LPD-PEG-NGR, an enhanced therapeutic effect was observed.
Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Doxorrubicina/administración & dosificación , Genes myc , Nanopartículas/administración & dosificación , Neoplasias/tratamiento farmacológico , Oligopéptidos/administración & dosificación , ARN Interferente Pequeño/administración & dosificación , Animales , Apoptosis , Antígenos CD13/farmacología , Línea Celular Tumoral , Sistemas de Liberación de Medicamentos , Endotelio Vascular , Células HT29 , Humanos , Liposomas , Ratones , Ratones Desnudos , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Aminopeptidase N (APN) is an essential peptidase involved in the process of tumor invasion and metastasis. Here we describe a novel class of inhibitor with 3-phenylpropane-1,2-diamine as scaffold to APN. Preliminary activity evaluation with enzyme inhibition studies showed that compound 12i exhibited potent and selective inhibitory activity towards APN with the IC(50) value 15.5+/-1.2microM.
Asunto(s)
Antígenos CD13/antagonistas & inhibidores , Diaminas/farmacología , Inhibidores de Proteasas/farmacología , Antígenos CD13/química , Antígenos CD13/farmacología , Células Cultivadas , Diaminas/síntesis química , Diaminas/química , Células HL-60 , Humanos , Concentración 50 Inhibidora , Metaloproteinasa 2 de la Matriz/farmacología , Inhibidores de la Metaloproteinasa de la Matriz , Microsomas/efectos de los fármacos , Microsomas/metabolismo , Inhibidores de Proteasas/síntesis química , Inhibidores de Proteasas/química , Relación Estructura-ActividadRESUMEN
During inflammation, cell surface adhesion molecules guide the adhesion and migration of circulating leukocytes across the endothelial cells lining the blood vessels to access the site of injury. The transmembrane molecule CD13 is expressed on monocytes and endothelial cells and has been shown to mediate homotypic cell adhesion, which may imply a role for CD13 in inflammatory monocyte trafficking. Here, we show that ligation and clustering of CD13 by mAb or viral ligands potently induce myeloid cell/endothelial adhesion in a signal transduction-dependent manner involving monocytic cytoskeletal rearrangement and filopodia formation. Treatment with soluble recombinant (r)CD13 blocks this CD13-dependent adhesion, and CD13 molecules from monocytic and endothelial cells are present in the same immunocomplex, suggesting a direct participation of CD13 in the adhesive interaction. This concept is strengthened by the fact that activated monocytic cells adhere to immobilized recombinant CD13. Furthermore, treatment with anti-CD13 antibodies in a murine model of peritonitis results in a decrease in leukocyte infiltration into the peritoneum, suggesting a potential role for CD13 in leukocyte trafficking in vivo. Therefore, this work supports a new direction for CD13 biology, where these cell surface molecules act as true molecular interfaces that induce and participate in critical inflammatory cell interactions.
Asunto(s)
Antígenos CD13/fisiología , Adhesión Celular/fisiología , Endotelio Vascular/fisiología , Monocitos/fisiología , Animales , Anticuerpos Monoclonales/farmacología , Antígenos CD/fisiología , Antígenos CD13/inmunología , Antígenos CD13/farmacología , Adhesión Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Endotelio Vascular/efectos de los fármacos , Femenino , Humanos , Ratones , Ratones Endogámicos , Monocitos/efectos de los fármacos , Peritonitis/fisiopatología , Proteínas Recombinantes/farmacología , Venas Umbilicales/fisiologíaRESUMEN
Membrane-bound peptidases interfere with cellular growth, differentiation, activation and death by fine-tuning local concentrations of various signaling peptides such as the growth factors, hormones, chemokines and cytokines. We examined the effects of anti-inflammatory cytokine transforming growth factor-beta(1) (TGF-beta(1)) on the expression and activity of aminopeptidase N (APN), an ectoenzyme processing several signaling peptides. Myelo-monocytic HL-60 cell line having high basal APN activity corresponding to the membrane CD13 marker served as a model. Regulation of CD13/APN was assayed at the levels of mRNA and at the membrane marker CD13. Functional properties of CD13/APN were examined by measuring the enzyme activity, and the signal transduction ability, followed as Ca(++) mobilization triggered by APN-blocking WM-15 antibody. TGF-beta(1) at physiological concentrations (0.16 to 2.5 ng/mL) increased expression of CD13 both at mRNA and membrane protein level in a time- and concentration-dependent manner. Transcriptional activation of CD13 by TGF-beta(1) is suggested as actinomycin-D, an inhibitor of RNA synthesis, abrogated the TGF-beta(1)-induced up-regulation of CD13. Increased membrane CD13 expression was associated with an increase of its enzyme (APN) activity and with a decrease of its signal transduction ability. Anti-inflammatory cytokine TGF-beta(1) counteracted the effects of pro-inflammatory cytokine IFN-gamma on membrane CD13 expression in a time- and concentration-dependent fashion, suggesting a cytokine-regulated role of CD13/APN in inflammation. This is the first report on regulation of CD13/APN expression by TGF-beta(1) on immature cells of myelo-monocytic origin. As obtained with physiological concentrations of TGF-beta(1) these findings may be relevant for cytokine-regulated CD13/APN expression on mature myeloid cells in the course of inflammation.
Asunto(s)
Antígenos CD13/biosíntesis , Factor de Crecimiento Transformador beta1/farmacología , Antibióticos Antineoplásicos/farmacología , Anticuerpos Bloqueadores/farmacología , Biomarcadores , Antígenos CD13/genética , Antígenos CD13/farmacología , Calcio/metabolismo , Diferenciación Celular/efectos de los fármacos , Dactinomicina/farmacología , Regulación hacia Abajo/efectos de los fármacos , Citometría de Flujo , Células HL-60 , Humanos , Interferón gamma/antagonistas & inhibidores , Interferón gamma/farmacología , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Receptores Fc/efectos de los fármacos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacosRESUMEN
Skin cells express dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related molecules of the DP IV-like family DP2, DP6, DP8, DP9 and fibroblast activation protein (FAP), as well as the cytoplasmic alanyl aminopeptidase (cAAP). The inhibitors of DP IV-like activity, Lys(Z(NO2))-thiazolidide (LZNT) and Lys(Z(NO2))-pyrrolidide (LZNP), and the APN inhibitors actinonin and bestatin affect proliferation, differentiation and cytokine production in sebocytes and keratinocytes, which are involved in the initiation of acne. Furthermore, they suppress proliferation of Propionibacterium acnes-stimulated T cells ex vivo and induce an anti-inflammatory cytokine profile. In the mouse tail model of psoriasis they have a pro-differentiative effect. In addition, these inhibitors suppress skin fibroblast proliferation, whereas only inhibition of DP IV-like activity decreases TGF-beta1 expression and abrogates the TGF-beta1 mediated stimulatory effects on TGF-beta1 and fibronectin production, collagen synthesis and matrix deposition in these cells. Targeting enzyme activity of DP IV and APN and their related molecules might be a novel approach for the treatment of acne, psoriasis or keloids.
Asunto(s)
Acné Vulgar/tratamiento farmacológico , Antígenos CD13/farmacología , Dipeptidil Peptidasa 4/fisiología , Enfermedades de la Piel/metabolismo , Animales , Antígenos CD13/química , Cricetinae , Dipeptidil Peptidasa 4/química , Inhibidores Enzimáticos/farmacología , Fibrosis , Humanos , Inflamación , Mesocricetus , Ratones , Modelos Biológicos , Psoriasis/terapia , Neoplasias Cutáneas/enzimología , Neoplasias Cutáneas/metabolismoRESUMEN
One sorting mechanism of apical and basolateral proteins in epithelial cells is based on their solubility profiles with Triton X-100. Nevertheless, apical proteins themselves are also segregated beyond the trans-Golgi network by virtue of their association or nonassociation with cholesterol/sphingolipid-rich microdomains (Jacob, R., and Naim, H. Y. (2001) Curr. Biol. 11, 1444-1450). Therefore, extractability with Triton X-100 does not constitute an absolute criterion of protein sorting. Here, we investigate the solubility patterns of apical and basolateral proteins with other detergents and demonstrate that the mild detergent Tween 20 is adequate to discriminate between apical and basolateral proteins during early stages in their biosynthesis. Although the mannose-rich forms of the apical proteins sucrase-isomaltase, lactase-phlorizin hydrolase, aminopeptidase N, and dipeptidylpeptidase IV reveal similar solubility profiles comprising soluble and nonsoluble fractions, the basolateral proteins, vesicular stomatitis virus G protein, major histocompatibility complex class I, and CD46 are entirely soluble with this detergent. The insoluble Tween 20 membranes are enriched in phosphatidylinositol and phosphatidylglycerol compatible with their synthesis in the endoplasmic reticulum and the existence of a novel class of detergent-resistant membranes. The association of the mannose-rich biosynthetic forms of the apical proteins, sucraseisomaltase, lactase-phlorizin hydrolase, aminopeptidase N, and dipeptidylpeptidase IV with the Tween 20-resistant membranes suggests an early polarized sorting mechanism prior to maturation in the Golgi apparatus.
Asunto(s)
Membrana Celular/metabolismo , Detergentes/farmacología , Células Epiteliales/citología , Adenosina Desaminasa/química , Animales , Antígenos CD13/farmacología , Células COS , Células CACO-2 , Línea Celular , Chlorocebus aethiops , Colesterol/metabolismo , Dipeptidil Peptidasa 4/química , Perros , Relación Dosis-Respuesta a Droga , Resistencia a Medicamentos , Retículo Endoplásmico/metabolismo , Células Epiteliales/patología , Glicoproteínas/química , Aparato de Golgi/metabolismo , Humanos , Hibridomas/metabolismo , Inmunoprecipitación , Cinética , Lactasa/química , Lactasa-Florizina Hidrolasa/química , Lípidos/química , Manosa/química , Proteína Cofactora de Membrana/biosíntesis , Microdominios de Membrana/química , Ratones , Octoxinol/farmacología , Oligo-1,6-Glucosidasa/química , Fosfatidilgliceroles/química , Fosfatidilinositoles/química , Polisorbatos/farmacología , Transporte de Proteínas , Esfingolípidos/metabolismo , Sacarasa/química , Sacarosa/farmacología , Transfección , Red trans-Golgi/metabolismoRESUMEN
OBJECTIVE: We previously showed that CD13/aminopeptidase N (EC 3.4.11.2) induces chemotactic migration of T lymphocytes by its enzymatic activity. In this study, we examined the role of CD13/aminopeptidase N in lymphocyte involvement in rheumatoid arthritis (RA). METHODS: Synovial fluids were obtained from 27 RA patients and 6 osteoarthritis (OA) patients. Synovial tissue specimens were obtained from 3 RA patients and 3 OA patients. Protease activity of aminopeptidase in synovial fluids and synovial fibroblasts was assayed fluorometrically using the specific substrate. Expression of CD13/aminopeptidase N in synovial fibroblasts was determined by flow cytometry analyses, Western blotting, and reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: The mean value of aminopeptidase activity in synovial fluid samples from RA patients was significantly higher than that in samples from OA patients. Increased enzymatic activity of aminopeptidase was detected on synovial fibroblasts from RA patients compared with those from OA patients. Flow cytometry showed that the expression of CD13/aminopeptidase N on synovial fibroblasts from RA patients was higher than the expression on synovial fibroblasts from OA patients, and Western blots and RT-PCR showed that synovial fibroblasts from RA patients contained a greater amount of CD13/aminopeptidase N. The activity of CD13/aminopeptidase N correlated significantly with lymphocyte counts in synovial fluids from RA patients. Synovial fluids from RA patients in which high aminopeptidase activity was detected contained considerable chemotactic activity for lymphocytes, and bestatin, a specific inhibitor of aminopeptidases, partially inhibited the chemotactic activity. CONCLUSION: CD13/aminopeptidase N may participate in the mechanism of lymphocyte involvement in inflamed joints of RA patients as a lymphocyte chemoattractant.
Asunto(s)
Artritis Reumatoide/fisiopatología , Antígenos CD13/farmacología , Articulaciones/fisiopatología , Leucina/análogos & derivados , Linfocitos/fisiología , Anciano , Artritis Reumatoide/metabolismo , Antígenos CD13/genética , Quimiotaxis de Leucocito/efectos de los fármacos , Femenino , Fibroblastos/enzimología , Humanos , Leucina/farmacología , Masculino , Persona de Mediana Edad , Osteoartritis/enzimología , Inhibidores de Proteasas/farmacología , ARN Mensajero/metabolismo , Líquido Sinovial/citología , Líquido Sinovial/enzimologíaRESUMEN
Betulinic acid (BetA), a pentacyclic triterpene, is a selective apoptosis-inducing agent that works directly in mitochondria. Recent study has revealed that BetA inhibits in vitro enzymatic activity of aminopeptidase N (APN, EC 3.4.11.2), which is known to play an important role in angiogenesis, but the anti-angiogenic activity of BetA has not been reported yet. Data presented here show that BetA potently inhibited basic fibroblast growth factor (bFGF)-induced invasion and tube formation of bovine aortic endothelial cells (BAECs) at a concentration which had no effect on the cell viability. To access whether the anti-angiogenic nature of BetA originates from its inhibitory action against aminopeptidase N (APN) activity, the effect of BetA on APN was investigated. Surprisingly, BetA did not inhibit in vivo APN activity in endothelial cells or APN-positive tumor cells. On the other hand, BetA significantly decreased the mitochondrial reducing potential, and treatment with mitochondrial permeability transition (MPT) inhibitors attenuated BetA-induced inhibition of endothelial cell invasion. These results imply that anti-angiogenic activity of BetA occurs through a modulation of mitochondrial function rather than APN activity in endothelial cells.
Asunto(s)
Aorta/citología , Antígenos CD13/farmacología , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Sustancias de Crecimiento/metabolismo , Neovascularización Patológica , Triterpenos/farmacología , Animales , Antineoplásicos Fitogénicos/farmacología , Antígenos CD13/metabolismo , Bovinos , Línea Celular Tumoral , Proliferación Celular , Supervivencia Celular , Colágeno/farmacología , Colorantes/farmacología , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Endotelio Vascular/metabolismo , Endotelio Vascular/patología , Laminina/farmacología , Mitocondrias/metabolismo , Mitocondrias/patología , Triterpenos Pentacíclicos , Permeabilidad , Proteoglicanos/farmacología , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sales de Tetrazolio/farmacología , Tiazoles/farmacología , Ácido BetulínicoRESUMEN
We have cloned a novel hematopoietic granulocyte colony-stimulating factor (G-CSF)-induced olfactomedin-related glycoprotein, termed hGC-1 (human G-CSF-stimulated clone-1). mRNA differential display was used in conjunction with a modified two-phase liquid culture system. Cultures were enriched for early precursors of erythroid, myeloid, and megakaryocytic lineages, which were isolated after induction with erythropoietin, G-CSF, and thrombopoietin, respectively. RNA from the enriched cells was subjected to differential display analysis to identify lineage-specific expressed genes. One clone specifically induced by G-CSF, hGC-1, was characterized. The 2861 bp cDNA clone of hGC-1 contained an open reading frame of 1530 nucleotides, translating into a protein of 510 amino acids with a signal peptide and six N-linked glycosylation motifs. The protein sequence of hGC-1 showed it to be a glycoprotein of the olfactomedin family, which includes olfactomedin, TIGR, Noelin-2 and latrophilin-1. Olfactomedin-like genes show characteristic tissue-restricted patterns of expression; the specific tissues expressing these genes differ among the family members. hGC-1 was strongly expressed in the prostate, small intestine, and colon, moderately expressed in the bone marrow and stomach, and not detectable in other tissues. In vitro translation and ex vivo expression showed hGC-1 to be an N-linked glycoprotein. The hGC-1 gene locus mapped to chromosome 13q14.3. Together, our findings indicate that hGC-1 is primarily expressed as an extracellular olfactomedin-related glycoprotein during normal myeloid-specific lineage differentiation, suggesting the possibility of a matrix-related function for hGC-1 in differentiation.
Asunto(s)
Proteínas Sanguíneas/genética , Proteínas de la Matriz Extracelular/genética , Glicoproteínas/genética , Factor Estimulante de Colonias de Granulocitos/genética , Células Mieloides/metabolismo , Amidohidrolasas/metabolismo , Secuencia de Aminoácidos , Antígenos CD/farmacología , Proteínas Sanguíneas/metabolismo , Western Blotting , Antígenos CD13/farmacología , Diferenciación Celular/efectos de los fármacos , Línea Celular , Mapeo Cromosómico , Cromosomas Humanos Par 13/genética , ADN Complementario/química , ADN Complementario/genética , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Glicoforinas/farmacología , Glicosilación , Factor Estimulante de Colonias de Granulocitos/metabolismo , Células HL-60 , Hematopoyesis/genética , Humanos , Hibridación Fluorescente in Situ , Integrina beta3 , Células K562 , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/efectos de los fármacos , Leucocitos Mononucleares/metabolismo , Masculino , Datos de Secuencia Molecular , Células Mieloides/citología , Células Mieloides/efectos de los fármacos , Péptido-N4-(N-acetil-beta-glucosaminil) Asparagina Amidasa , Glicoproteínas de Membrana Plaquetaria/farmacología , Biosíntesis de Proteínas , Alineación de Secuencia , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Células Tumorales CultivadasRESUMEN
The specific enzymatic activity of four different aminopeptidases (aminopeptidase N, leucine aminopeptidase, aminopeptidase A and aminopeptidase B) in vaginal homogenates from rabbit, rat, guinea-pig, sheep and humans was compared. The purpose of the study was to find an appropriate animal model that can be used in degradation studies of protein and peptide drugs. Different substrates were used as the relative specific substrates for the determination of aminopeptidase enzymatic activity: 4-methoxy-2-naphthylamide of L-alanine for aminopeptidase N, 4-methoxy-2-naphthylamide of L-leucine for leucine aminopeptidase, 4-methoxy-2-naphthylamide of L-glutamic acid for aminopeptidase A and 4-methoxy-2-naphthylamide of L-arginine for aminopeptidase B. The vaginal aminopeptidase enzymatic activity of different species was determined spectrofluorometrically. The inhibition of aminopeptidase activity in the presence of bestatin and puromycin inhibitors was also investigated. The results showed the presence of aminopeptidase enzymatic activity in all vaginal homogenates in the order: sheep > guinea-pig > rabbit > or = human > or = rat. Based on the results of the hydrolysis and inhibition of the 4-methoxy-2-naphthylamide substrates, it was difficult to have an exact decision on the aminopeptidase type in the vaginal homogenates from the species studied. It was found that the aminopeptidase activity in rat, rabbit and humans was not statistically different. Therefore, we suggest that rats and rabbits could be used as model animals for vaginal enzymatic activity studies and for determination of the degradation of protein and peptide drugs in the vagina.
Asunto(s)
2-Naftilamina/análogos & derivados , Alanina/análogos & derivados , Aminopeptidasas/metabolismo , Leucina/análogos & derivados , Leucil Aminopeptidasa/metabolismo , Vagina/enzimología , 2-Naftilamina/metabolismo , Alanina/metabolismo , Aminoácidos/metabolismo , Aminopeptidasas/efectos de los fármacos , Animales , Antígenos CD13/farmacología , Femenino , Glutamil Aminopeptidasa , Cobayas , Humanos , Leucina/farmacología , Leucil Aminopeptidasa/efectos de los fármacos , Inhibidores de Proteasas/farmacología , Inhibidores de la Síntesis de la Proteína/farmacología , Puromicina/farmacología , Conejos , Ratas , Ratas Wistar , Ovinos , Vagina/citologíaRESUMEN
Rheumatoid synovitis is characterized by an infiltration of mononuclear cells and by the proliferation of synoviocytes. Monocytes and synoviocytes are major producers of cytokines, growth factors, and enzymes that contribute to the rheumatoid arthritis (RA) process. Since they are in close contact in vivo, we engaged in an in vitro study of the functional consequences of their interactions. Coculture of unstimulated elutriated normal blood monocytes over RA synoviocytes resulted in a synergistic increase of the production of IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), leukemia inhibitory factor (LIF), and IL-8, when compared with their respective production in culture alone. In contrast, cytokines such as IL-10, IL-1 beta, IL-1 alpha, and TNF-alpha could not be detected. The IL-6 production in coculture was further increased by the addition of IL-1 beta, GM-CSF, IFN-gamma, or TNF-alpha, but was inhibited by the addition of IL-10, IL-4, IL-13, or IL-1Ra, an effect reverted by the addition of IL-1 beta. Moreover, an inhibition was also observed with anti-CD14 mAb and newly raised mAbs directed against RA synoviocytes. Under reducing conditions, the mAb SY12 precipitated a 150-kDa surface membrane protein, identified as amino-peptidase N (CD13/AP-N). Collectively, these results indicate that 1) monocytes and synoviocytes interact with each other to produce proinflammatory cytokines, 2) pro- and antiinflammatory cytokines have opposite effects on IL-6 production, and 3) molecules such as IL-1, CD14, and CD13 are involved.
Asunto(s)
Artritis Reumatoide/inmunología , Antígenos CD13/farmacología , Interleucina-1/farmacología , Interleucina-6/biosíntesis , Receptores de Lipopolisacáridos/farmacología , Monocitos/inmunología , Membrana Sinovial/inmunología , Agregación Celular , Fibroblastos/citología , Fibroblastos/inmunología , Humanos , Monocitos/citología , Membrana Sinovial/citologíaRESUMEN
The present investigation initially determined that a commercially available aminopeptidase M (AmM, Sigma Chemical) can lower blood pressure when intracerebroventricularly (ICV) infused in spontaneously hypertensive rats (SHR). Pretreatment with the angiotensin II (AngII) receptor subtype 1 (AT1) antagonist, DuP 753 (losartan) significantly attenuated this hypotensive effect, in a dose-dependent manner, while pretreatment with the AngII receptor subtype 2 (AT2) antagonist, PD123177, did not influence AmM-induced hypotension. These results suggest that AT1 receptors may be involved in the hypotension accompanying the ICV infusion of AmM; however, the relationship among available AT1 sites, angiotensin ligands, and peptidase activity appears to be complicated with the likely involvement of additional, as yet unspecified, brain peptide systems possessing cardiovascular action.
Asunto(s)
Antagonistas de Receptores de Angiotensina , Compuestos de Bifenilo/farmacología , Presión Sanguínea/efectos de los fármacos , Antígenos CD13/farmacología , Hipertensión/fisiopatología , Imidazoles/farmacología , Tetrazoles/farmacología , Animales , Inyecciones Intraventriculares , Losartán , Masculino , Piridinas/farmacología , Ratas , Ratas Endogámicas SHRRESUMEN
Aminopeptidase (APN) was found to degrade interleukin-8 (IL-8) and inactivate its chemotactic activity. The chemotactic activity of IL-8 was decreased by APN or neutrophil plasma membranes dose- and time-dependently. The chemotactic activity was not inactivated in the presence of bestatin or WM15 monoclonal antibody. The expression of IL-8 was measured by flow cytometry. On lipopolysaccharide (LPS) stimulation, IL-8 expression increased for 60 min and then decreased markedly. In contrast, on treatment with LPS and bestatin, the expression of IL-8 increased continuously for at least 120 min. These results suggest that the expression and release of IL-8 from phagocytic cells are regulated by the proteolytic effect of APN on IL-8.